# FDA Inspection 1024597 - Biomat USA, Inc. - July 26, 2017

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/997e2c70-0471-4f57-b8f4-aef72cb456a0
Source feed: FDA_Inspections

> FDA Inspection 1024597 for Biomat USA, Inc. on July 26, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1024597
- Company Name: Biomat USA, Inc.
- Inspection Date: 2017-07-26
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1209304 - 2023-06-15](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/434514d3-4426-474b-b6f4-8c1b268218aa)
- [FDA Inspection 1209304 - 2023-06-15](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/8f11af5a-728a-43bd-9f80-547fd409270c)
- [FDA Inspection 849943 - 2013-09-19](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/45697ca5-38a6-45fd-a175-4ee2c099b80c)
- [FDA Inspection 680996 - 2010-09-10](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/5b4c90b0-f2da-4d53-9a44-e5e1ebd0e137)

Company: https://www.keypedia.com/companies/biomat-usa-inc/7c4a83d5-bc60-4351-ab37-94428e858011

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d